Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-02

Clinical Trial Update: GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection [Phase 3]

View source ↗

Summary

Phase 3 trial update for a fixed-dose combination of saquinavir/ritonavir in treatment-naive HIV-1 infection; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saquinavir/ritonavir (saquinavir/ritonavir)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2011-11-02